This invention relates to a
recombinant hirudin fusion protein with collagen affinity, its preparation method, and its applications. The
fusion protein is a
recombinant hirudin fusion protein incorporating a collagen-
binding domain (CBD). The fusion
protein of this invention possesses affinity for type I and
type III collagen, and can inhibit
thrombin activity to exert an
anticoagulant effect. Furthermore, it can bind well to collagen-based composite materials, making it suitable for use in cardiovascular implants such as heart valves, cardiac occluders,
dialysis membranes,
oxygenation membranes, artificial blood vessels, and
vascular stents, as well as in
extracorporeal circulation and
blood purification devices, enhancing
anticoagulant and
antithrombotic effects.